Related Experiment Video
Updated: Mar 28, 2026

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
MicroRNA-222 regulates MMP-13 via targeting HDAC-4 during osteoarthritis pathogenesis
Jinsoo Song1, Eun-Heui Jin1, Dongkyun Kim1
1Department of Biological Sciences, College of Natural Sciences, Wonkwang University, Iksan, Chunbuk 570-749, Korea.
Background:
Even though increasing evidences on miRNA involvement in human pathological responses, the distinct roles and related mechanisms of miRNAs in the pathology of osteoarthritis (OA) are not yet fully understood.
Method:
RNA levels or protein levels of Apoptotic genes, HDACs, MMP-13, and miRNAs in human chondrocytes isolated from normal biopsy sample and OA cartilages were analyzed by real-time PCR or western blotting. Exogenous modulation of miR-222 level was performed using delivery of its specific precursor or specific inhibitor and target validation assay was applied to identify its potent target. In vivo study using DMM mice model was performed and assessed the degree of cartilage degradation.
Results:
According to miRNA profiling, miR-222 was significantly down-regulated in OA chondrocytes. Over-expression of miR-222 significantly suppressed apoptotic death by down-regulating HDAC-4 and MMP-13 level. Moreover, 3'-UTR reporter assays showed that HDAC-4 is a direct target of miR-222. The treatment of chondrocytes with the HDAC inhibitor, trichostatin A (TSA), suppressed MMP-13 protein level and apoptosis, whereas the over-expression of HDAC-4 displayed opposite effects. The introduction of miR-222 into the cartilage of medial meniscus destabilized mice significantly reduced cartilage destruction and MMP-13 level.
Conclusion:
Taken together, our data suggest that miR-222 may be involved in cartilage destruction by targeting HDAC-4 and regulating MMP-13 level.
Insights
MicroRNA-222 (miR-222) is down-regulated in osteoarthritis (OA) and targeting HDAC-4 suppresses cartilage destruction by regulating MMP-13 levels, offering potential OA therapeutic strategies.
Area of Science:
- Molecular Biology
- Biochemistry
- Genetics
Background:
- MicroRNAs (miRNAs) play roles in pathological responses, but their specific functions in osteoarthritis (OA) pathogenesis remain unclear.
- Understanding miRNA mechanisms is crucial for developing novel OA treatments.
Purpose of the Study:
- To investigate the role of miR-222 in OA pathology.
- To identify the molecular targets and mechanisms of miR-222 in chondrocytes.
Main Methods:
- Analysis of miRNA, apoptotic gene, HDAC, and MMP-13 levels in human OA chondrocytes.
- In vitro manipulation of miR-222 levels and target validation assays.
- In vivo studies using a destabilized medial meniscus (DMM) mouse model.
Main Results:
- miR-222 was significantly downregulated in OA chondrocytes.
- Overexpression of miR-222 suppressed apoptosis and reduced HDAC-4 and MMP-13 levels.
- HDAC-4 was identified as a direct target of miR-222.
- In vivo miR-222 delivery reduced cartilage destruction and MMP-13 levels in DMM mice.
Conclusions:
- miR-222 plays a protective role in OA by targeting HDAC-4 and regulating MMP-13.
- miR-222 represents a potential therapeutic target for osteoarthritis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
MicroRNAs
MicroRNAs
The JAK-STAT Signaling Pathway

